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Significance and Impact of the Study: The metal ions, molybdenum, rhenium, thallium and yttrium were
tested against both Klebsiella pneumoniae and Acinetobacter baumannii in planktonic and biofilm
forms. This research demonstrated that all the metal ions may be effective antimicrobial agents. How-
ever, molybdenum induced high levels of cytotoxicity, whilst, there was no significant difference in the
toxicity of the other metal ions tested. When considering the results for the antimicrobial efficacy and
biotoxicity of the metal ions, in conjunction with the known toxicity of thallium in certain chemical com-
positions, it was concluded that overall rhenium or yttrium ions may be effective antimicrobial agents,
one potential application may be utilizing these metal ions in hospital surface cleaning formulations.
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Abstract
Antimicrobial resistance presents major global concerns to patient health. In this
study, metal ions of molybdenum, rhenium, yttrium and thallium were tested
against bacteria in planktonic and biofilm form using one strain of Klebsiella
pneumoniae and Acinetobacter baumannii. The antimicrobial efficacy of the metal
ions was evaluated against the planktonic bacterial strains using minimum
inhibitory concentrations (MICs) and minimum bactericidal concentrations,
whilst the efficacy of the metal ions against biofilms was tested using a crystal
violet biofilm assay. Live Dead staining was used to visualize the antimicrobial
activity elicited by the metal ions on the bacterial cell. The results showed that
higher concentrations of the metals were required to inhibit the growth of
biofilms (729 mg l1 to 4167 mg l1), in comparison to their planktonic
counterparts. MICs of the metal ions (<469 mg l1) (planktonic cells) did not
affect biofilm formation. Overall, rhenium and yttrium were effective
antimicrobial agents. Molybdenum demonstrated the greatest level of biotoxicity.
When taking into account these results and the known toxicity of thallium, it is
possible that rhenium or yttrium ions could be developed as effective biocidal
formulations in order to prevent transmission in healthcare environments.
Introduction
Hospital-acquired infections place a huge burden upon
healthcare services, dramatically increasing mortality rates
whilst also placing an economic strain on the health ser-
vices. In the UK, hospital acquired infections affect
around 1 in 10 patients during their stay in hospital
(Breathnach 2005) and cost the NHS approximately
£3000 per patient (Magill et al. 2014).
Antimicrobial resistance (AMR) often occurs due to
over persistent use of antimicrobials, such as antibiotics.
Excessive use of antibiotics in agriculture and the over-
prescribing of antibiotics to patients have added a selec-
tive pressure on micro-organisms (Laxminarayan et al.
2013). A study from the Centre for Disease Control and
Prevention (CDC), suggests that antimicrobial resistance
accounts for around 23 000 deaths annually in the USA
alone (CDC, 2013). Acinetobacter baumannii has been
1© 2019 The Authors. Letters in Applied Microbiology published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Letters in Applied Microbiology ISSN 0266-8254
estimated to account for up to 10% of all hospital-
acquired infections (Joly-Guillou 2005). Klebsiella pneu-
moniae has been shown to be the second highest causative
agent of hospital acquired infections, after Escherichia coli,
possibly due to its prevalence in gastrointestinal infections
(Vading et al. 2018). Furthermore, the analysis of 50 bac-
terial isolates from urinary catheters has demonstrated
that 16% were Klebsiella spp., whilst 2% were Acinetobac-
ter spp. (Niveditha et al. 2012).
Hospital equipment and surfaces can act as potential
reservoirs for micro-organisms and the transmission of
pathogenic bacteria to patients may lead to secondary
hospital-acquired infections (Weinstein and Hota 2004).
Several bacteria have been shown to survive for months
on dry hospital contact surfaces, including Acinetobacter
spp., which survived in a vegetative state for between
3 days to 11 months (final extinction was noted on day
343) and Klebsiella spp., remained viable between 2 h and
30 months (Wagenvoort and Joosten 2002; Otter et al.
2013). Therefore, there is an urgent need for effective bio-
cidal regimes to be developed and deployed. This would
involve the development of biocidal formulations with
enhanced antimicrobial activity, but with little or no
human toxicity at the same concentrations, in order to
destroy possible bacterial reservoirs and reduce the
exacerbated risk of transmission of infection in Hospital
settings.
It has been suggested that conventional in vitro antimi-
crobial susceptibility testing methods which target sessile
cells are not suitable for evaluating the efficiency of candi-
date antimicrobials (Weinstein and Hota 2004; Jacqueline
and Caillon 2014). Several studies have shown that bio-
films can demonstrate antimicrobial resistance greater
than that exhibited by sessile bacterial cells (Bjarnsholt
et al. 2005; Macia et al. 2014). Smith and Hunter (2008)
reported that 80% of the methicillin resistant Staphylococ-
cus aureus (MRSA) and Pseudomonas aeruginosa biofilms
remained viable after the application of hospital biocides.
Metal ions may provide in part a biocidal solution as
they have the ability to bind to and block functional
groups (i.e. thiol groups) in bacterial cells (Stiefel et al.
2015). The interaction with such functional groups can
displace and disrupt essential metals in bacterial enzymes,
leading to dysregulation of protein synthesis, bacterial
DNA synthesis and ultimately, the loss of cell membrane
integrity resulting in cell death (Hobman and Crossman
2015). In previous work, we have demonstrated the
antimicrobial activity of other metal ions in solution, how-
ever, this work did not look at either the biofilm or cyto-
toxicity effects of the antimicrobials (Vaidya et al. 2018).
Although such metal ions may be suggested for use as
biocidal agents, that may be potentially used in hospital
surface cleaning formulations, the properties of the metals
is dependent on their form, ions can cause toxicity in ani-
mals and humans. Thallium is known to be more acutely
toxic than other metals (Bannon 2015). The thallium ion
(Ti+) has a charge similar to that of potassium ions,
allowing it to easily enter cells and compete with potas-
sium-dependent biological systems, one example of this is
Ti+ ions binding to Na/K-ATPase (Britten and Blank
1968; Cotton and Wilkinson 1980). Yet 201thallium, is
used in myocardial perfusion imaging with for detection
and evaluation of coronary artery disease (Beller 1994).
Thus, the extent of metal toxicity is ultimately dependent
on its form. For example, the lethal dose, 50% (LD50)
for thallium acetate in brown rats is 412 mg kg1 (mod-
erately toxic) and 16 mg kg1 for thallium sulphate
(highly toxic). In contrast, the transitional metals
rhenium, yttrium and molybdenum are considered practi-
cally nontoxic (LD50 (single oral dose for rats) 5000–
15 000 mg kg1) (Misra et al. 2003; Egorova and Anani-
kov 2017). Although molybdenum toxicity is rare in
humans, there have been reports of molybdenum toxicity
associated with dietary supplement overdose, which mani-
fests with copper deficiency, gout-like symptoms and neu-
rotoxicity (Vyskocil and Viau 1999).
In order to determine the possibility of the use of some
lesser used metal ions as antimicrobial agents, this funda-
mental study tested the determination of minimum inhi-
bitory concentration (MIC), minimum bactericidal
concentration (MBC) crystal violet biofilm assay and Live
Dead Staining of the biofilms against two known Gram-
negative hospital pathogens, Klebsiella pneumoniae and
Acinetobacter baumanii. The metal ions also needed to
demonstrate low eukaryotic cellular toxicity, in order to
determine if they could potentially be advantageous for
use in novel biocidal formulations. Eukaryotic cytotoxicity
was determined against the human renal proximal tubular
HK-2 cell line. A renal cell line was chosen for this study,
as it has been demonstrated that one of the main target
organs for some metal toxicity is the kidneys, for example
thallium has been shown to accumulate in the kidneys of
poisoned people and to induce kidney lesions (Leonard
and Gerber 1997).
Results and discussion
An antimicrobial resistant strain of both, A. baumannii
and K. pneumoniae were used in these assays. A. bauman-
nii demonstrated inhibition by Tetracycline 25 lg, Strep-
tomycin 25 lg, Kanamycin 30 lg and Colistin Sulphate
100 lg whilst, K. pneumoniae demonstrated inhibition by
Colistin Sulphate 100 lg, Nalidixic Acid 30 lg, Nitrofura-
toin 50 lg and Streptomycin 25 lg (data not presented).
The MIC investigations on planktonic strains of A.
baumannii and K. pneumoniae revealed that molybdenum
2 © 2019 The Authors. Letters in Applied Microbiology published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology.
Antimicrobial efficacy metal ions A.J. Slate et al.
demonstrated the greatest bactericidal activity against
both strains (65 mg l1; 62 mg l1) (Fig. 1a). This
result was significantly different when compared to the
other metal ions (P < 005). Rhenium ions were the next
most effective inhibitory antimicrobial agent against A.
baumannii and K. pneumoniae at 130 mg l1 and
117 mg l1 respectively.
The MBC investigations on the planktonic strains A.
baumannii and K. pneumoniae revealed that against A.
baumannii, there was no significant difference between
the activity of the metal ion (1800 mg l1 to
2083 mg l1). Yttrium demonstrated the greatest antimi-
crobial activity against K. pneumoniae (729 mg l1),
although this was not significantly different the bacterici-
dal activity of the other metal ions (Fig. 1b).
The crystal violet biofilm assay was used to quantify
the antimicrobial effect of the metal ions at their
predetermined MBCs. Against A. baumannii and K. pneu-
moniae, all the metal ions demonstrated a significant
decrease in biofilm formation when compared to the con-
trol (P < 005) (Fig. 2) The exception was the use of the
rhenium ions against K. pneumoniae which did reduce
the amount of biofilm, but it was not significant when
compared to the control (Fig. 2b).
Results from the Live Dead staining which enabled the
antimicrobial activity of the metals to be visualized,
revealed damage to the bacterial cell walls following treat-
ment with the metal ions. Although thallium was found
to provide the most damage to the cell walls of K. pneu-
moniae (8512%) there was no significant difference in
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Figure 1 Minimum inhibitory concentrations (MICs) (a) and minimum
bactericidal concentrations (MBCs) (b) of metal ion solutions against
planktonic strains of Klebsiella pneumoniae and Acinetobacter bau-
mannii (n = 3). *P ≤ 005. Note the log difference in the y-axis ( ) A.
baumannii and ( ) K. pneumoniae.
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Figure 2 The optical density of (a) Acinetobacter baumannii and (b)
Klebsiella pneumoniae crystal violet-stained biofilm material at
540 nm following incubation of the metal ion solutions at their mini-
mum bactericidal concentrations concentrations (n = 6). *P ≤ 005;
**P ≤ 001, ***P ≤ 0001.
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the amount of cell wall damage produced between the
thallium, rhenium and yttrium ions (Fig. 3).
Assays carried out to determine the toxicity of 50 mg l1
of metal ions against the eukaryotic HK-2 cell line revealed
that cell viability was significantly reduced by molybdenum
(04%) followed by rhenium (423%), thallium (517%) and
yttrium (541), as compared to the control cells (Fig. 4).
This study suggests that higher concentrations of metal
ions are required to inhibit biofilms as opposed to their
planktonic counterparts. This is in agreement with previ-
ous literature as it was demonstrated that a variety of
metal ions tested against planktonic and biofilm-forming
strains of E. coli, S. aureus and P. aeruginosa were 2–64
times less effective at destroying bacterial biofilms, in
comparison to logarithmically growing planktonic bacte-
rial strains (Harrisson et al. 2004).
In agreement with our work, Harrisson et al. (2004)
demonstrated that molybdenum ions (MoO4
+) showed
antimicrobial activity against planktonic and biofilm-form-
ing strains of E. coli, S. aureus and P. aeruginosa. Previous
work has shown that mono/di-rhenium complexes have
demonstrated antimicrobial activity against Gram-positive
S. aureus and Gram-negative E. coli (Kumar et al. 2016).
Rhenium ions were also tested in combination with cipro-
floxacin (in vivo), where they destroyed bacterial cells by
disrupting DNA gyrase synthesis (Lecina et al. 2014).
molybdenum-rhenium coated struts have been used for
applications within replacement heart-valve components
(Beall mitral valves) (Ribeiro et al. 2016).
With regards to the antimicrobial activity of thallium,
it has been reported that thallium ions and similar sized
metal ions have the ability to replace sodium and potas-
sium ions in biologically relevant systems. The metal ions
can accumulate in the bacterial cells via the transporter
excitatory amino acid carrier 1 (Tao et al. 2008). This
transporter is essential and highly conserved, as its pri-
mary function is to mediate electrochemical transmem-
brane gradients. However, in contradiction to our
eukaryotic assay results, it must be noted that thallium is
an extremely toxic metal (Britten and Blank 1968; Cotton
and Wilkinson 1980; Bannon 2015). This result may be
due to the ionic form that the thallium is used in this
study and an expanded investigation into reducing the
biotoxicity of thallium in this form is currently underway.
Yttrium has also demonstrated antimicrobial activity.
Yttrium fluoride nanoparticle complexes were evaluated
as antimicrobial surface coatings, and the results showed
that yttrium successfully inhibited both E. coli and S. aur-
eus biofilm formation, due to surface adherence inhibition
(Lellouche et al. 2012). The structural conformation of
metals can vary (i.e. metal ions, nanoparticles and oxi-
des); this results in a diverse range of antimicrobial activ-
ity for the same chemical species. However, this study
provides evidence that using yttrium ions as a bactericidal
component has potential.
In conclusion, considering the results for the antimi-
crobial efficacy, biotoxicity and the results reported by
others in the literature, it is possible that metals such as
rhenium and yttrium in ionic form could be developed
into effective biocidal formulations for use in surface
decontamination in hospitals to prevent the transmission
of bacteria.
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Figure 3 Percentage number of dead cells following Dead staining of
the Klebsiella pneumoniae and Klebsiella pneumoniae biofilms after
7 days. *P ≤ 005, **P ≤ 001, ***P ≤ 0001 ( ) A. baumannii and
( ) K. pneumoniae.
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Figure 4 Viability of HK-2 cells exposed to 50 mg l1 metal ion solu-
tions for 26 h. The cells were bound to the surface before treatment.
The viability is expressed as percentage of the viability of control cells
(PBS in serum-free medium) (n = 6) ****P ≤ 00001.
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Materials and methods
Agar and broth preparation
The agar used in this study included nutrient agar (NA),
nutrient broth (NB), for K. pneumoniae and tryptone soya
agar (TSA) tryptone soya broth (TSB) for A. baumannii.
(obtained from Oxoid, Hampshire, UK).
Bacterial preparation
Acinetobacter baumannii (NCTC 12156) and Klebsiella
pneumoniae (NCTC 9633) were recovered from 80°C
stock cultures and transferred onto nutrient agar for 24 h
at 37°C. Isolated bacterial colonies were transferred into
20 ml of the appropriate broth and mixed with a vortex
shaker for 5 s. The broth suspension was transferred to a
shaking incubator (200 rev min1) and incubated at 37°C
for 24 h. In order to wash the bacterial cells, the cellular
suspension was mixed with a vortex mixer for 5 s and
then centrifuged for 10 min (1721 g). The supernatant
was removed and replaced with 20 ml of sterile distilled
water and vortexed for 5 s, then centrifuged again at
1721 g for 10 min. The supernatant was discarded and
20 ml of sterile broth was added to the washed cells and
vortexed for 5 s. The broth suspensions were standardized
to an optical density (OD) of 10 at 540 nm (01) to
obtain bacterial concentrations of 50 9 108 CFU per ml
using a spectrophotometer (Jenway, Staffordshire, UK).
The bacterial strains were tested using antimicrobial mul-
tidiscs (MAST, Liverpool, UK). One hundred microlitres
of prepared bacterial suspension was spread across the
agar and the antimicrobial multidisc was placed on top.
The inoculated agar with the discs was incubated at 37°C
for 24 h following which the zones on inhibition were
measured to determine antibiotic sensitivity (n = 3).
Determination of minimum inhibitory concentration
(MIC)
Bacterial broth preparations of A. baumannii and K.
pneumoniae standardized to OD 10 were inoculated onto
the appropriate broth. Triphenyl tetrazolium chloride
solution (TTC) 15% (w/v) (Sigma, Dorset, UK) was pre-
pared in sterile distilled water and mixed until the TCC
had dissolved completely. The TCC solution was further
diluted to give a final concentration of 015% w/v. One
column acted as a positive control and another as a nega-
tive control. The 96 well microtest plate (MTP) was cov-
ered and sealed with Parafilm, and the MTPs were
incubated at 37C for 24 h (aerobic conditions; without
agitation). Following incubation, wells that contained liv-
ing/viable cells had produced a purple colour, this was a
result of the TTC becoming enzymatically reduced to
1,3,5-triphenylformazan. The first well in each column to
display no colour change was taken as the minimum inhi-
bitory concentration (MIC).
Minimum bactericidal concentration
To determine the minimum bactericidal concentrations
(MBC), 20 ll of the bacterial suspension was taken from
each MIC well showing no growth and also from the
wells identified as the MIC and placed onto appropriate
agar. The agar plates with the bacterial suspensions were
dried for 1 h at room temperature and then incubated at
37°C for 24 h. Upon incubation, the lowest concentration
that showed no growth was taken to be the MBC.
Preparation of stainless steel coupons
Stainless steel coupons 1 cm 9 1 cm in size (304 bright
annealed finish, Outokumpu, UK) were cleaned for use in
the biofilm assays by submerging them for 10 min into
10 ml 100% acetone, dried at room temperature then trans-
ferred into 10 ml 100% methanol for 10 min and dried
again. The coupons were placed into 70% ethanol for
10 min, dried and submerged into sterile distilled water for
10 min and dried at room temperature. Finally, the sterile
coupons were placed in a sterile Petri dish where they were
stored until needed.
Crystal violet biofilm assay
To produce biofilms on the metal surfaces, stainless steel
coupons (1 cm 9 1 cm) were placed into each well of a
12 well, flat-bottomed culture plate with the polished side
facing upwards and 1 ml of broth suspension was pipet-
ted into each well. The metal ions were added to the wells
with a negative control well which included bacteria but
not the antimicrobial agents. The 12-well plate lid was
then closed and sealed using Parafilm sheets to prevent
the broth from evaporating during incubation. The inoc-
ulated well plates were incubated for 7 days at 37°C in
aerobic conditions with no agitation. Following incuba-
tion, the broth was discarded and the coupons were dried
for 1 h at room temperature in a type biosafety cabinet
(Atlas Clean Air, Preston, UK).
The metals ions were diluted into sterile distilled water
to obtain the predetermined MBC values. A negative con-
trol was also included, this included bacteria and not the
antimicrobial agents. One millilitre of the metal ions was
pipetted into a well containing the stainless steel coupon
with the biofilm. Each metal ion solution and control was
pipetted into individual wells, sealed using Parafilm r
and incubated for 24 h at 37°C after which the metal ions
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were discarded. Following incubation, the coupons were
rinsed by pipetting 1 ml of sterile water gently against the
coupon in the MTP well and dried at room temperature
for 1 h in a type 2 biosafety cabinet.
One millilitre of 01% crystal violet was pipetted into
each of the wells and was left to stand for 30 min to stain
the biofilm. The stainless steel coupons were rinsed by
gently pipetting 1 ml of sterile water (carefully so as not
to disrupt the biofilm) over the coupons, before transfer-
ring them into a sterile 12-well culture plate.
To determine the optical density of the biofilms on the
metal ions following incubation, the coupons were air-
dried for 1 h, then 1 ml 33% glacial acetic acid was pipet-
ted into the wells to solubilize the crystal violet-stained
biofilm and left to stand for 30 min. One millilitre of the
solubilized biofilm was taken from each well and pipetted
into a cuvette and its OD was measured at 540 nm using
a spectrophotometer (Jenway) (n = 3).
Live Dead staining
The bacterial suspensions were incubated on the stainless
steel coupons for 7 days at 37°C. Following incubation,
the inoculated broth was removed and discarded and the
coupons were dried for 1 h at room temperature in a
type 2 biosafety cabinet. The metals ions were diluted to
their previously determined MBC values. One millilitre of
the metal ions was added to each of the stainless steel
coupons, this was left to stand for 10 min. The metal ions
were then discarded and the coupons were dried at room
temperature (1 h), in a type 2 biosafety cabinet.
A Live Dead BacLightTM Bacterial Viability Kit (Fisher
Scientific, Loughborough, UK) was used to carry out Live
Dead staining of the biofilm which was then visualized
using an epifluorescence microscope (Nikon, Surrey, UK).
An initial staining solution was prepared using 30 ll of
SYTO9, 30 ll of Propidium iodide pipetted into 10 ml
of filter-sterilized deionised water. The coupons had 1 ml
of the prepared solution applied to the biofilms and were
placed in the dark for 30 min. The solution was discarded
and the coupons were dried at room temperature for 1 h
in a type 2 biosafety cabinet, in the dark. The coupons
were visualized using an epifluorescence microscope.
Epifluorescence microscopy
Using an epifluorescence microscope (Nikon Eclipse E600;
Nikon) samples were visualized with 9100 objective and
Type F immersion oil (Leica Microsystems, Milton Keynes,
UK). CELL F (Olympus, Southend-on-Sea, UK) software
was used to visualize and produce images of the samples
and the percentage Live Dead coverage was calculated by
quantifying the fluorescence emitted. To calculate Live
Dead coverage, the images were visualized under different
filters in the range of 510 nm–560 nm for the SYTO 9
stain and 590 nm–650 nm for the propridium iodide
stain. The percentage number of viable and nonviable bac-
teria was quantified using the threshold function on the
CELL F software.
Mammalian cell culture and viability test
Viability tests were carried out to determine the cytotoxic
effect of the metals on immortalized human renal proxi-
mal tubular epithelial HK-2 cells (CRL-2190, ATCC, UK).
Briefly, the HK-2 cells were maintained in humidified
incubators at 5% CO2 and 37°C in 50 : 50
DMEM : Ham’s F-12 medium supplemented with
5 mmol l1 glucose, 25 mmol l1 glutamine, 10% foetal
calf serum, 50 U ml1 penicillin and 50 lg ml1 strepto-
mycin. Cells were seeded at a density of 9000 cells per
well in 96-well plates and incubated for 24 h. The cells
were then rinsed with phosphatebuffered saline and the
growth arrested for 24 h in serum-free medium (SFM;
50 : 50 DMEM : Ham’s F-12 medium supplemented with
5 mmol l1 glucose, 25 mmol l1 glutamine, 50 U ml1
penicillin and 50 lg ml1 streptomycin).
The pH of the metal solutions was adjusted to pH 65–
7 using 2 mol l1 NaOH and the solutions were diluted
50 mg l1 in SFM. Upon the 24 h growth arrest, the cells
reached confluence of 100%. The SFM was aspirated and
replaced with 200 ll of either 50 ng l1 of metal ions in
SFM or PBS in SFM for 23 h. Then 10 ll of WST-8
reagent (Cell Counting Kit-8; Dojindo Molecular Tech-
nologies, Peterborough, UK) was added to each well and
the formation of soluble WST-8 formazan was detected
after 3 h of incubation at 37°C by the use of a microplate
reader at 450 nm wavelength.
Statistical analysis
A one-way ANOVA test was used to compare the treatment
groups. Tukey’s HSD post hoc test was carried out when
significant P-values (P < 005) were detected. All n values
indicate experimental replications.
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